Good morning :)
Place Order
Add to Watchlist
Home
Portfolio
Search
digi goldGold
More

Themis Medicare Ltd

THEMISMED

Themis Medicare Ltd

THEMISMED
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,658 cr, stock is ranked 1,047
High RiskStock is 4.61x as volatile as Nifty
180.000.14% (-0.25)
180.000.14% (-0.25)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,658 cr, stock is ranked 1,047
High RiskStock is 4.61x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,658 cr, stock is ranked 1,047
High RiskStock is 4.61x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
32.394.890.28%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
44.585.120.70%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Themis Medicare Limited is engaged in manufacturing pharmaceuticals and medicinal chemicals, such as formulations and active pharmaceutical ingredients.

Investor Presentation

View older 

Aug 17, 2023

PDF
View Older Presentations

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 12.02%, vs industry avg of 8.45%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.11% to 0.12%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 38.19%, vs industry avg of 9.82%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue214.48235.63220.73215.11188.69213.96243.77412.49379.44395.71
Raw Materialssubtract92.1787.3874.5373.1568.8166.6779.48145.08126.16310.42
Power & Fuel Costsubtract8.3610.839.778.419.7011.4911.3212.1811.83
Employee Costsubtract32.6436.3040.0044.6545.6944.2839.9951.9766.15
Selling & Administrative Expensessubtract24.3926.8735.5737.2035.2826.3426.9644.7351.04
Operating & Other expensessubtract26.3532.9023.9821.0822.0017.1523.4345.0231.70
Depreciation/Amortizationsubtract11.4911.897.477.427.998.278.559.4810.4911.57
Interest & Other Itemssubtract14.5312.3311.8411.8711.8212.8812.718.779.569.47
Taxes & Other Itemssubtract-1.660.851.600.04-1.862.095.6322.3815.6113.04
EPS0.731.921.821.24-1.172.703.897.936.185.56
DPS0.180.180.000.000.000.180.430.500.500.50
Payout ratio0.250.090.000.000.000.060.110.060.080.09
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF

Investor Presentation

May 15PDF
Feb 9PDF
Nov 9PDF
FY 2024

Annual Report Pending

Investor Presentation

Aug 17PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Themis Medicare Ltd29.154.890.28%
Sun Pharmaceutical Industries Ltd34.864.980.93%
Cipla Ltd35.054.140.70%
Dr Reddy's Laboratories Ltd21.264.120.70%

Price Comparison

Compare THEMISMED with any stock or ETF
Compare THEMISMED with any stock or ETF
THEMISMED
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding

Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding67.16%0.00%0.01%0.05%32.78%

Dec 2022

Mar 2023

Jun 2023

Sep 2023

Shareholding History

JunSepDec '22MarJunSep0.00%0.02%0.02%0.06%0.04%0.05%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 1, 2023

Final
Final | Div/Share: ₹5.00

Dividend/Share

₹5.00

Ex DateEx Date

Sep 1, 2023

Cash Dividend

Ex DateEx DateSep 8, 2022

Final
Final | Div/Share: ₹5.00

Dividend/Share

₹5.00

Ex DateEx Date

Sep 8, 2022

Cash Dividend

Ex DateEx DateSep 8, 2021

Final
Final | Div/Share: ₹4.30

Dividend/Share

₹4.30

Ex DateEx Date

Sep 8, 2021

Cash Dividend

Ex DateEx DateSep 17, 2020

Final
Final | Div/Share: ₹1.75

Dividend/Share

₹1.75

Ex DateEx Date

Sep 17, 2020

Cash Dividend

Ex DateEx DateJul 20, 2011

Final
Final | Div/Share: ₹3.00

Dividend/Share

₹3.00

Ex DateEx Date

Jul 20, 2011